| Schedule Of Interest Expenses |
Total debt consists of the following as of June 30, 2017 and December 31, 2016: | | | June 30, | | | December 31, | | | | | | | | ($ in thousands) | | 2017 | | | 2016 | | | Interest rate | | | Maturity | | IDB Note | | $ | 14,929 | | | $ | 14,929 | | | | 2.25 | % | | Feb - 2018 | | NSC Note | | | 3,608 | | | | 3,608 | | | | 8.00 | % | | Sep - 2018 | | 2017 Subordinated Note Financing | | | 3,254 | | | | - | | | | 8.00 | % | | March - 2020 | | 2017 Subordinated Note Financing | | | 13,893 | | | | - | | | | 8.00 | % | | May - 2020 | | 2017 Subordinated Note Financing | | | 1,820 | | | | - | | | | 8.00 | % | | June - 2020 | | Opus Credit Facility | | | 9,500 | | | | 7,000 | | | | 12.00 | % | | Sep - 2018 | | Helocyte Convertible Note, at fair value | | | 1,076 | | | | 1,031 | | | | 5.00% - 8.00% | | | December 2017 | | Helocyte Convertible Note, at fair value | | | 2,135 | | | | 2,051 | | | | 5.00% - 8.00% | | | March - 2018 | | Helocyte Convertible Note, at fair value | | | 1,032 | | | | 991 | | | | 5.00% - 8.00% | | | April - 2018 | | Helocyte Convertible Note, at fair value | | | 430 | | | | 414 | | | | 5.00% - 8.00% | | | May - 2018 | | Avenue Convertible Note, at fair value | | | - | | | | 200 | | | | 5.00% - 8.00% | | | June - 2018 | | Total notes payable | | | 51,677 | | | | 30,224 | | | | | | | | | Less: Discount on notes payable | | | 4,723 | | | | 2,009 | | | | | | | | | Total notes payable | | $ | 46,954 | | | $ | 28,215 | | | | | | | |
|
| Schedule Of Interest Expenses For Debt Arrangements |
The following table shows the details of interest expense for all debt arrangements during the periods presented. Interest expense includes contractual interest and amortization of the debt discount and amortization of fees represents fees associated with loan transaction costs, amortized over the life of the loan: | | | For the Three Months Ended June 30, | | For the Three Months Ended June 30, | | | ($ in thousands) | | 2017 | | 2016 | | 2017 | | 2016 | | | IDB Note | | | | | | | | | | | | | | | Interest | | $ | 87 | | $ | 79 | | $ | 169 | | $ | 159 | | | Amortization of fees | | | - | | | - | | | - | | | 1 | | | Total IDB Note | | | 87 | | | 79 | | | 169 | | | 160 | | | | | | | | | | | | | | | | | | NSC Debt | | | | | | | | | | | | | | | Interest | | | 84 | | | 144 | | | 155 | | | 311 | | | Amortization of fees | | | 40 | | | 54 | | | 73 | | | 422 | | | Total NSC Debt | | | 124 | | | 198 | | | 228 | | | 733 | | | | | | | | | | | | | | | | | | NHLD Debt | | | | | | | | | | | | | | | Interest | | | 406 | | | - | | | 406 | | | - | | | Amortization of fees | | | 175 | | | - | | | 175 | | | - | | | Total NHLD Debt | | | 581 | | | - | | | 581 | | | - | | | | | | | | | | | | | | | | | | Opus Credit Facility | | | | | | | | | | | | | | | Interest | | | 276 | | | - | | | 508 | | | - | | | Amortization of fees | | | 241 | | | - | | | 454 | | | - | | | Total Opus Note | | | 517 | | | - | | | 962 | | | - | | | | | | | | | | | | | | | | | | LOC Fees | | | | | | | | | | | | | | | Interest | | | 7 | | | 3 | | | 15 | | | 7 | | | Total LOC | | | 7 | | | 3 | | | 15 | | | 7 | | | | | | | | | | | | | | | | | | Helocyte Convertible Note | | | | | | | | | | | | | | | Interest | | | 57 | | | - | | | 111 | | | - | | | Financing fee | | | - | | | 249 | | | 1 | | | 249 | | | Total Helocyte Convertible Note | | | 57 | | | 249 | | | 112 | | | 249 | | | | | | | | | | | | | | | | | | Avenue Convertible Note | | | | | | | | | | | | | | | Interest | | | 5 | | | - | | | 5 | | | - | | | Financing fee | | | - | | | - | | | 3 | | | - | | | Total Helocyte Convertible Note | | | 5 | | | - | | | 8 | | | - | | | | | | | | | | | | | | | | | | D&O Insurance | | | | | | | | | | | | | | | Interest | | | 2 | | | - | | | 3 | | | - | | | Total D&O Insurance | | | 2 | | | - | | | 3 | | | - | | | Total Interest Expense and Financing Fee | | $ | 1,380 | | $ | 529 | | $ | 2,078 | | $ | 1,149 | |
|